rxstat › Shortages › Flecainide
Flecainide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Flecainide products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 17, 2026.
In shortage since
Oct 31, 2025
Est. full return
Jul 17, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageJAMP FLECAINIDE
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493705 · since Oct 31, 2025, est. end Jul 17, 2026 · Demand increase for the drug.
ResolvedAPO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
DiscontinuedNRA-FLECAINIDE
100MG · TABLET · NORA PHARMA INC
DIN 02530074
DiscontinuedNRA-FLECAINIDE
50MG · TABLET · NORA PHARMA INC
DIN 02530066
ResolvedFLECAINIDE
100MG · TABLET · SANIS HEALTH INC
DIN 02534819 · ended Jan 22, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-FLECAINIDE
100MG · TABLET · APOTEX INC
DIN 02275546 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
ResolvedAURO-FLECAINIDE
100MG · TABLET · AURO PHARMA INC
DIN 02459965 · ended Jun 24, 2024 · Demand increase for the drug.
ResolvedAPO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Feb 15, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Sep 6, 2023 · Disruption of the manufacture of the drug.
ResolvedJAMP FLECAINIDE
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493705 · ended Feb 17, 2023 · Disruption of the manufacture of the drug.
ResolvedJAMP FLECAINIDE
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493713 · ended Feb 17, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
Flecainide is currently affected by an active shortage report filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Flecainide is classified under “ANTIARRHYTHMICS, CLASS I AND III” (ATC C01BC).
Recent changes
Common questions
When will Flecainide be back in stock in Canada?
The latest manufacturer estimate is Jul 17, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Flecainide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.